BIM-22103 (Ipsen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBIM-22103 (Ipsen)
Drug Alias NameBIM-22103
ClassificationBiologics
Mechanisms of ActionMelanocortin receptor 4 agonists
TargetsMelanocortin receptor 4
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIpsen
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A